Teriflunomide Stada

Teriflunomide Stada is an oral medication used to treat multiple sclerosis. This disease-modifying therapy helps reduce relapses and slow disease progression. It belongs to the immunomodulatory class of drugs. Always follow healthcare provider guidance when using.

Teriflunomide Stada is prescribed to reduce the frequency of relapses and delay physical disability in adults with relapsing forms of multiple sclerosis. It is also used to manage symptoms associated with this condition. Patients often ask, 'what is teriflunomide used for' in relation to MS treatment options.

Teriflunomide Stada works by modulating the immune system to reduce inflammation in the central nervous system. Users may notice improved mobility and fewer flare-ups over time. Individual responses vary based on treatment duration and adherence. Regular monitoring is recommended to assess effectiveness.

Teriflunomide Stada should be used under medical supervision due to potential effects on the liver and immune system. Patients with liver problems or severe infections should discuss risks with their doctor. Blood tests are typically required before and during treatment to monitor safety.

Teriflunomide Stada may interact with other medications that affect the liver, such as certain antibiotics or antiepileptics. Combining it with immunosuppressants or live vaccines could increase risks. Alcohol use should be limited, as it may worsen side effects. Always inform your healthcare provider about all medications.